artemisinin-based combination therapies

Malaria is endemic in the Central African Republic (CAR). That means that a large number of the country's inhabitants are infected at least once a year. The disease is the primary public health...

Web article – Last updated 25 April 2012
www.msfaccess.org/content/malaria-%E2%80%93-one-leading-causes-death-central-african-republic

What is Malaria? Malaria is a parasitic infection transmitted from person to person by the bite of infected female Anopheles mosquitoes. These mosquitoes usually bite from around dusk to dawn. Once...

Briefing – Last updated 24 April 2012
www.msfaccess.org/content/fact-sheet-malaria

Authors from MSF and Harvard School of Public Health have published a critical analysis of the role of tiered pricing to improve access to medicines in developing countries. The study was presented...

In Medical Journals / Research Articles – Last updated 15 November 2011
www.msfaccess.org/content/win-win-solution-critical-analysis-tiered-pricing-improve-access-medicines-developing

MSF has always striven to find new and better ways of saving lives and improving the health of more people.  Our teams are regularly faced with a lack of needed medical tools to do their job. From its...

Static page – Last updated 12 August 2011
www.msfaccess.org/content/msf-medical-innovation

ASAQ: A real step forward in malaria treatment The World Health Organization recommends artemisinin-based combinations, or ACTs, to treat malaria throughout much of the world. One barrier to implementation...

Static page – Last updated 28 July 2011
www.msfaccess.org/content/rd-developing-simpler-and-more-affordable-treatment

Medical advances in treating malaria  For decades, malaria was treated with drugs such as chloroquine or sulfadoxine-pyrimethamine (SP, often known by its brand name, Fansidar). However, after overwhelming...

Static page – Last updated 21 December 2011
www.msfaccess.org/content/treating-malaria

In 1999, in the wake of Médecins Sans Frontières (MSF) being awarded the Nobel Peace Prize, MSF launched the Access Campaign. Its purpose has been to push for access to, and the development of life-saving...

Static page – Last updated 21 December 2011
www.msfaccess.org/the-access-campaign

Why was the AMFm established? The Affordable Medicines Facility for malaria was set up with the aim of increasing access to new and effective malaria treatment. For decades now treating malaria has...

Web article – Last updated 01 January 2009
www.msfaccess.org/content/affordable-medicines-facility-malaria-amfm

Geneva, 8 April 2009 – A global malaria drug subsidy to be launched this month is failing to look at medical needs and is jeopardising the future of the most effective malaria treatments that...

Press Release – Last updated 21 December 2011
www.msfaccess.org/about-us/media-room/press-releases/new-malaria-drug-subsidy-fails-ensure-patients-receive-best

Executive Director Global Fund to Fight AIDS, Tuberculosis and Malaria Chemin de Blandonnet 8 1214 Vernier Geneva, Switzerland January 27, 2009 Dear Dr. Kazatchkine, Médecins...

Statements, Speeches, Letters – Last updated 02 February 2009
www.msfaccess.org/content/msfs-letter-global-fund-calling-amfm-exclusively-endorse-use-fdcs-0